' It ' s Not Every Day ' This Response Rate Seen in TNBC ' It ' s Not Every Day ' This Response Rate Seen in TNBC

A novel targeted therapy provided an incremental improvement in response rate among breast cancer patients with poor prognoses -- those with heavily pretreated metastatic triple-negative breast cancer (TNBC).Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news